Levrat-Guillen F - Search Results

1

Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study.

Roussel R, Riveline JP, Vicaut E, de Pouvourville G, Detournay B, Emery C, Levrat-Guillen F, Guerci B. Roussel R, et al. Diabetes Care. 2021 Jun;44(6):1368-1376. doi: 10.2337/dc20-1690. Epub 2021 Apr 20. Diabetes Care. 2021. PMID: 33879536 Free PMC article.

2

Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF Study.

Riveline JP, Roussel R, Vicaut E, de Pouvourville G, Detournay B, Emery C, Levrat-Guillen F, Guerci B. Riveline JP, et al. Among authors: levrat guillen f. Diabetes Technol Ther. 2022 Sep;24(9):611-618. doi: 10.1089/dia.2022.0085. Epub 2022 Jul 11. Diabetes Technol Ther. 2022. PMID: 35604792

3

Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France.

Guerci B, Roussel R, Levrat-Guillen F, Detournay B, Vicaut E, De Pouvourville G, Emery C, Riveline JP. Guerci B, et al. Among authors: levrat guillen f. Diabetes Technol Ther. 2023 Jan;25(1):20-30. doi: 10.1089/dia.2022.0271. Epub 2022 Nov 24. Diabetes Technol Ther. 2023. PMID: 36094418

4

FreeStyle Libre Flash Glucose Monitoring system for people with type 1 diabetes in the UK: a budget impact analysis.

Blissett R, Blissett D, Levrat-Guillen F, Deshmukh H, Wilmot EG, Ryder REJ, Walton C, Sathyapalan T. Blissett R, et al. BMJ Open Diabetes Res Care. 2022 Mar;10(2):e002580. doi: 10.1136/bmjdrc-2021-002580. BMJ Open Diabetes Res Care. 2022. PMID: 35346970 Free PMC article.

5

Premature and Incomplete Overview of Health Technology Assessments for Flash Glucose Monitoring Leads to Misleading Conclusions.

Hellmund R, Blissett D, Levrat-Guillen F. Hellmund R, et al. J Diabetes Sci Technol. 2019 May;13(3):601-602. doi: 10.1177/1932296818822513. Epub 2018 Dec 31. J Diabetes Sci Technol. 2019. PMID: 30595051 Free PMC article. No abstract available.

6

Cost-Effectiveness of the FreeStyle Libre^® System Versus Blood Glucose Self-Monitoring in Individuals with Type 2 Diabetes on Insulin Treatment in Sweden.

Jendle J, Eeg-Olofsson K, Svensson AM, Franzen S, Lamotte M, Levrat-Guillen F. Jendle J, et al. Diabetes Ther. 2021 Dec;12(12):3137-3152. doi: 10.1007/s13300-021-01172-1. Epub 2021 Oct 25. Diabetes Ther. 2021. PMID: 34694584 Free PMC article.

7

Cost-Effectiveness of Intermittently Scanned Continuous Glucose Monitoring Versus Advanced Hybrid Closed-Loop Systems in Type 1 Diabetes: Comment on Jendle et al.

Levrat-Guillen F, Ghazi T. Levrat-Guillen F, et al. Diabetes Ther. 2022 May;13(5):1121-1123. doi: 10.1007/s13300-022-01251-x. Epub 2022 Apr 11. Diabetes Ther. 2022. PMID: 35403951 Free PMC article. No abstract available.

8

Sensor-Based Technology: Bringing Value to People with Diabetes and the Healthcare System in an Evolving World.

Glennie JL, Berard L, Levrat-Guillen F. Glennie JL, et al. Clinicoecon Outcomes Res. 2022 Feb 10;14:75-90. doi: 10.2147/CEOR.S346736. eCollection 2022. Clinicoecon Outcomes Res. 2022. PMID: 35177913 Free PMC article. Review.

9

The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation.

Szafranski K, De Pouvourville G, Greenberg D, Harris S, Jendle J, Shaw JE, Castro JC, Poon Y, Levrat-Guillen F. Szafranski K, et al. Among authors: levrat guillen f. Value Health. 2024 Apr;27(4):500-507. doi: 10.1016/j.jval.2024.01.010. Epub 2024 Feb 1. Value Health. 2024. PMID: 38307388 Free article.

10

How Continuous Glucose Monitoring Can Motivate Self-management: Can Motivation Follow Behaviour?

Vallis M, Ryan H, Berard L, Cosson E, Kristensen FB, Levrat-Guillen F, Naiditch N, Rabasa-Lhoret R, Polonsky W. Vallis M, et al. Among authors: levrat guillen f. Can J Diabetes. 2023 Jul;47(5):435-444. doi: 10.1016/j.jcjd.2023.04.001. Epub 2023 Apr 11. Can J Diabetes. 2023. PMID: 37044242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page